Skip to main content
. 2016 Aug 10;11(8):e0160062. doi: 10.1371/journal.pone.0160062

Fig 1. Overview of patient enrollment and adjudicated treatment outcomes at 24 weeks.

Fig 1

DS: drug susceptible; IR: INH resistant, MDR: multi drug-resistant.